Potentially, PDX models, autochthonous genetically engineered mouse melanoma models, or ex vivo tumor explant culture might have allowed us to maintain more features of melanoma in which to assess the impact of DGAT1 depletion or antagonism. This evidence concerns the gene DGAT1 and melanoma.